SevenBridge Financial Group’s Biogen BIIB Stock Holding History

SevenBridge Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-337	Closed	-$79K	–	186
2019 Q2	$79K	Hold	337	–	–	0.03%	223
2019 Q1	$80K	Sell	337 -17	-5%	-$5.35K	0.03%	199
2018 Q4	$107K	Hold	354	–	–	0.07%	155
2018 Q3	$125K	Hold	354	–	–	0.07%	158
2018 Q2	$103K	Sell	354 -215	-38%	-$60.4K	0.06%	179
2018 Q1	$156K	Sell	569 -20	-3%	-$6.21K	0.09%	149
2017 Q4	$188K	Sell	589 -248	-30%	-$79.6K	0.1%	141
2017 Q3	$262K	Sell	837 -42	-5%	-$12.4K	0.15%	124
2017 Q2	$239K	Sell	879 -125	-12%	-$33.1K	0.15%	123
2017 Q1	$270K	Sell	1,004 -27	-3%	-$7.63K	0.18%	109
2016 Q4	$304K	Hold	1,031	–	–	0.22%	101
2016 Q3	$304K	Buy	1,031 +29	+3%	+$8.59K	0.22%	101
2016 Q2	$242K	Buy	+1,002	New	+$264K	0.17%	114

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SevenBridge Financial Group's BIIB Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Biogen (BIIB) in Q3 2019, closing a stake of 337 shares — an estimated $79K sold.

SevenBridge Financial Group first reported a position in BIIB in Q2 2016 and held it in 13 quarters. The position peaked at $304K in Q4 2016. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

SevenBridge Financial Group reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
SevenBridge Financial Group sold 337 Biogen shares in Q3 2019, an estimated $79K.
SevenBridge Financial Group first reported a position in Biogen in Q2 2016 and held it in 13 quarters.
SevenBridge Financial Group's Biogen position peaked at $304K in Q4 2016.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.